Skip to main content

Day: July 8, 2025

Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services, committed the next USD 39 million to Basilea to continue to advance the development of Basilea’s novel antifungals fosmanogepix and BAL2062. This additional funding is based on the successful completion of a milestone within the “Other Transaction Agreement” (OTA, agreement number 75A50124C00033) that was awarded on September 30, 2024, and which allows for potential...

Continue reading

Diginex Announces Plans for Eight-for-One Forward Stock Split

LONDON, July 07, 2025 (GLOBE NEWSWIRE) — Diginex Limited (“Diginex” or the “Company”) (NASDAQ: DGNX), a leading provider of Sustainability RegTech solutions, today announced that on July 1, 2025 the Diginex Board of Directors (the “Board”) adopted resolutions recommending that its shareholders approve an eight-for-one (8:1) forward stock split.  The Board has scheduled an extraordinary general meeting of its shareholders to be held on July 29, 2025 (the “EGM”) for shareholders of record as of July 3, 2025 (the “Record Date”) to vote on the forward stock split and the filing of a second amended and restated memorandum and articles of association (the “Proposals”). Should the Proposals be approved by shareholders the forward stock split will be effective from August 1, 2025.  Should the Proposals be approved at the EGM, (i) each...

Continue reading

Perseus Mining Quarterly Report Investor Webinar

Perth, July 08, 2025 (GLOBE NEWSWIRE) — QUARTERLY REPORT INVESTOR WEBINAR / CALL Perth, Western Australia/July 8, 2025/Perseus Mining Limited (ASX/TSX: PRU) is hosting an investor webinar and conference call to discuss its June 2025 Quarterly Results, which are anticipated for release around 8:30am AEST on Monday July 28, 2025. CALL DETAILSAustralia: Monday July 28, 2025 Perth – 7:00am Sydney/Melbourne – 9:00am Canada: Sunday July 27, 2025 Vancouver – 4:00pm Toronto – 7:00pm UK: Monday July 28, 2025 London – 12:00amRegister for the investor webinar at the link below: https://us02web.zoom.us/webinar/register/WN_GsgXaXPGQhe2MCZ3T4Vp9w After registering, you will receive a confirmation email containing information about joining the webinar. To join the webinar via telephone, please use one of the following numbers and enter...

Continue reading

Fluence Chosen for 300 MW / 600 MWh Wellington Battery Energy Storage System for AMPYR Australia

Fluence Chosen for 300 MW / 600 MWh Wellington Battery Energy Storage System for AMPYR AustraliaJulian Nebreda, President and Chief Executive Officer, Fluence, and Alex Wonhas, AMPYR Australia CEO.The project will include the full suite of Fluence’s innovative storage products, including Gridstack™, a 20-year service contract, Mosaic bidding software, and Nispera asset performance management software SYDNEY, July 08, 2025 (GLOBE NEWSWIRE) — Fluence Energy, Inc. (“Fluence”) (NASDAQ: FLNC), a global market leader delivering intelligent energy storage, services, and asset optimization software, today announced that the company has been selected by AMPYR Australia (AMPYR) for the 300 MW / 600 MWh Wellington Stage 1 Battery Energy Storage System (BESS) in Wellington, New South Wales, Australia. AMPYR has contracted...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.